tiprankstipranks
Advertisement
Advertisement

INAB Stock Latest News

IN8bio Reports Q1 2026 Results and Shareholder Votes
Company AnnouncementsIN8bio Reports Q1 2026 Results and Shareholder Votes
24d ago
8K
INAB
Is INAB a Buy, Before Earnings?
PremiumPre-Earnings
Is INAB a Buy, Before Earnings?
3M ago
INAB
IN8bio Announces Board Resignation and Interim Chair Appointment
PremiumCompany Announcements
IN8bio Announces Board Resignation and Interim Chair Appointment
3M ago
8K
INAB
IN8bio Elevates COO Kate Rochlin to President
PremiumCompany Announcements
IN8bio Elevates COO Kate Rochlin to President
4M ago
8K
INAB
IN8bio appoints Kate Rochlin as president
PremiumThe Fly
IN8bio appoints Kate Rochlin as president
4M ago
INAB
IN8bio files to sell 14.38M shares of common stock for holders
PremiumThe FlyIN8bio files to sell 14.38M shares of common stock for holders
4M ago
INAB
IN8bio: Clinical Momentum, Strengthened Cash Runway, and Unmodeled Pipeline Upside Support Buy Rating
Premium
Ratings
IN8bio: Clinical Momentum, Strengthened Cash Runway, and Unmodeled Pipeline Upside Support Buy Rating
5M ago
INAB
IN8bio presents Phase I/II data from INB-200 trials
Premium
The Fly
IN8bio presents Phase I/II data from INB-200 trials
5M ago
INAB
IN8bio Announces Structured $40 Million Private Placement Financing
PremiumCompany Announcements
IN8bio Announces Structured $40 Million Private Placement Financing
5M ago
8K
INAB
IN8bio prices 5.13M shares at $1.38 in private placement
PremiumThe Fly
IN8bio prices 5.13M shares at $1.38 in private placement
5M ago
INAB
IN8bio Presents Promising Clinical Trial Results
PremiumCompany Announcements
IN8bio Presents Promising Clinical Trial Results
6M ago
8K
INAB
IN8bio files $200M mixed securities shelf
PremiumThe Fly
IN8bio files $200M mixed securities shelf
7M ago
INAB
IN8Bio Reports Improved Financials Amid Ongoing Challenges
PremiumCompany AnnouncementsIN8Bio Reports Improved Financials Amid Ongoing Challenges
7M ago
INAB
IN8bio expands INB-100 Phase 1 trial with new clinical site
Premium
The Fly
IN8bio expands INB-100 Phase 1 trial with new clinical site
7M ago
INAB
IN8bio Unveils Promising Preclinical Data for INB-619
Premium
Company Announcements
IN8bio Unveils Promising Preclinical Data for INB-619
7M ago
8K
INAB
IN8bio presents new preclinical data from INB-619
PremiumThe Fly
IN8bio presents new preclinical data from INB-619
7M ago
INAB
IN8bio price target adjusted to $4 from $60 at Mizuho
PremiumThe Fly
IN8bio price target adjusted to $4 from $60 at Mizuho
8M ago
INAB
Positive Outlook on IN8bio: Buy Rating Backed by Promising Pipeline Developments and Strategic Financial Adjustments
PremiumRatings
Positive Outlook on IN8bio: Buy Rating Backed by Promising Pipeline Developments and Strategic Financial Adjustments
10M ago
INAB
In8bio, Inc. Reports Improved Financial Performance
PremiumCompany Announcements
In8bio, Inc. Reports Improved Financial Performance
10M ago
INAB
IN8bio reports Q2 EPS ($1.24), consensus ($1.80)
PremiumThe FlyIN8bio reports Q2 EPS ($1.24), consensus ($1.80)
10M ago
INAB
IN8bio Regains Nasdaq Compliance with Bid Price Rule
Premium
Company Announcements
IN8bio Regains Nasdaq Compliance with Bid Price Rule
11M ago
8K
INAB
IN8bio recognizes 4-years in remission for patient treated with INB-200
Premium
The Fly
IN8bio recognizes 4-years in remission for patient treated with INB-200
12M ago
INAB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >